Alnylam Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2013-03-31 | $5.8M | 238k | 24.37 |
| 2012-12-31 | $3.5M | 190k | 18.25 |
| 2012-09-30 | $4.2M | 224k | 18.79 |
| 2012-06-30 | $2.5M | 217k | 11.65 |
| 2012-03-31 | $363k | 33k | 11.07 |
| 2011-12-31 | $565k | 69k | 8.15 |
| 2011-09-30 | $722k | 110k | 6.57 |
| 2011-06-30 | $544k | 58k | 9.37 |
| 2011-03-31 | $1.5M | 158k | 9.56 |
| 2010-12-31 | $419k | 43k | 9.86 |